WorldPingUltragenyx said its experimental therapy for Angelman syndrome, a rare disease, showed no benefit compared to a sham treatment in a Phase 3 trial.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATMore coverage: all health news on WorldPing.
“Broken heart syndrome” can mimic a heart attack so closely that patients often need invasive testing to tell the difference.
Brief by WorldPing · Original reporting by ScienceDaily
WorldPingDawn Light is accused of taking photos of jurors outside the Plymouth courthouse, a practice prohibited by the court.
Brief by WorldPing · Original reporting by BBC News
WorldPing